Selling And Administration Expenses 更改
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Almirall EUR 134.46M 10.26M 2023-06
Amarin USD 45.46M 5.5M 2023-09
Amgen USD 1.76B 424M 2023-12
AstraZeneca USD 3.91B 194M 2023-09
Bayer EUR 3.6B 81M 2023-09
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Bluebird Bio USD 40.7M 354K 2023-09
Demant DKK 5.49B 135M 2023-06
Exelixis USD 138.14M 3.58M 2023-09
Fresenius Medical Care EUR 794M 19M 2023-09
Galapagos EUR 60.57M 2.92M 2023-09
Genmab DKK 839M 9M 2023-09
GlaxoSmithKline GBP 2.18B 6M 2023-09
GN Store Nord DKK 1.43B 62M 2023-09
GRIFOLS EUR 353.2M 52.88M 2023-12
Hikma Pharmaceutical USD 260M 7M 2023-06
Insmed USD 89.53M 1.1M 2023-12
Merck EUR 1.42B 68M 2023-09
Regeneron Pharmaceuticals USD 737.7M 97.2M 2023-12
Roche Holding CHF 6.51B 26M 2023-06
UCB EUR 857M 12M 2023-06



Genmab 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.